Generics - Patents

Filter

Current filters:

Patents

Popular Filters

1 to 25 of 231 results

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Breckenridge Pharma files ANDA for generic of Sanofi’s Jevtana

12-02-2015

Privately-held US generic drugmaker Breckenridge Pharmaceutical has filed an Abbreviated New Drug Application…

Breckenridge PharmaceuticalsGenericsJevtanaOncologyPatentsRegulationSanofiUSA

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

10-02-2015

US generics drugmaker Mylan has confirmed that it has been sued by German pharma major Bayer and partner…

BayerGenericsLegalMylanNexavarOncologyOnyx PharmaceuticalsPatentsPatents & Trade marksRegulationUSA

Supernus sues TWi for infringement of Oxtellar XR patents

22-01-2015

US drugmaker Supernus Pharmaceuticals says that it has sued generic drug makers Taiwan-based TWi Pharmaceuticals…

GenericsLegalNeurologicalOxtellar XRPatentsSupernus PharmaceuticalsTWi PharmaceuticalsUSA

Supernus sues Par for Trokendi XR patents infringement

19-01-2015

US drugmaker Supernus Pharmaceuticals says it has sued privately-held generics firm Par Pharmaceutical…

GenericsLegalNeurologicalPar PharmaceuticalsPatentsSupernus PharmaceuticalsTrokendi XRUSA

Akorn files ANDA for generic Durezol

16-01-2015

US generic drugmaker Akorn has confirmed that it has filed an Abbreviated New Drug Application (ANDA)…

AkornAlconDurezolGenericsNovartisOphthalmicsPatentsRegulationUSA

Helsinn settles with Sandoz over Aloxi in USA

12-01-2015

Privately-held Swiss cancer specialist Helsinn Group say it has entered into a settlement agreement with…

AloxiEisaiGenericsHelsinn GroupLegalNovartisOncologyPatentsSandozUSA

Supernus notified of Par Pharma ANDA filing for Trokendi XR generic

09-12-2014

US drugmaker Supernus Pharmaceuticals says that it has received a Paragraph IV Notice Letter from privately-held…

GenericsNeurologicalPar PharmaceuticalsPatentsRegulationSupernus PharmaceuticalsTrokendi XRUSA

AstraZeneca wins in US Nexium pay-for-delay litigation

AstraZeneca wins in US Nexium pay-for-delay litigation

07-12-2014

Anglo-Swedish pharma major AstraZeneca revealed on Friday that a jury in the US District Court for the…

AstraZenecaGastro-intestinalsGenericsLegalNexiumPatentsRanbaxyUSA

Mylan confirms first-to-file patent challenge relating to Brevibloc

25-11-2014

US generic drugmaker Mylan today confirmed that it and several subsidiaries have been sued by US drugmaker…

Baxter InternationalBreviblocCardio-vascularGenericsLegalMylanPatentsRegulationUSA

Supernus sues Zydus for infringement of Trokendi XR patents

25-11-2014

US drugmaker Supernus Pharmaceuticals has sued generic drug makers Zydus Pharmaceuticals (USA) and Indian…

GenericsLegalNeurologicalPatentsSupernus PharmaceuticalsUSAZydus Cadila

Pfizer prevails in Sutent patent dispute

Pfizer prevails in Sutent patent dispute

23-10-2014

The US District Court for the District of Delaware has upheld US pharma giant Pfizer’s basic patent…

GenericsLegalMylanOncologyPatentsPfizerSutentUSA

US Appeals Court upholds Lo Loestrin Fe patent

US Appeals Court upholds Lo Loestrin Fe patent

23-10-2014

Ireland-headquartered generics major Actavis confirmed that it has prevailed in a court battle over the…

ActavisAmneal PharmaceuticalsGenericsLegalLo LoestrinLupinPatentsReproductiveUSAWomen's Health

Actavis challenges Quillivant XR patent

16-10-2014

Ireland-headquartered generics major Actavis confirmed that it has filed an Abbreviated New Drug Application…

ActavisGenericsLegalNeurologicalPatentsPfizerQuillivantRegulationTris PharmaUSA

Supernus sues Actavis for Trokendi XR patents infringement

Supernus sues Actavis for Trokendi XR patents infringement

02-10-2014

USA-based specialty drug firm Supernus Pharmaceuticals says it has sued generic drugmaker Actavis and…

ActavisGenericsLegalNeurologicalPatentsSupernus PharmaceuticalsTrokendi XRUSA

Update: Negotiations on EU-Canada Free Trade Agreement concluded

Update: Negotiations on EU-Canada Free Trade Agreement concluded

29-09-2014

Canadian trade group Research-Based Pharmaceutical Companies (Rx&D) expressed its support to the government…

CanadaEuropeGenericsMarkets & MarketingPatentsPoliticsRegulation

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

Teva gets positive UK judgment in case against AstraZeneca

Teva gets positive UK judgment in case against AstraZeneca

03-09-2014

A positive judgment has been given by the UK High Court in support of Israeli generic drug giant Teva…

AstraZenecaDuoResp SpiromaxGenericsLegalPatentsRespiratory and PulmonarySymbicortTeva Pharmaceutical IndustriesUK

United Thera scores over Sandoz in Remodulin patent case

United Thera scores over Sandoz in Remodulin patent case

31-08-2014

US biotech company United Therapeutics’ shares leapt 28.5% to $117.83 on Friday, after the company…

GenericsLegalNovartisPatentsRemodulinRespiratory and PulmonarySandozUnited TherapeuticsUSA

1 to 25 of 231 results

COMPANY SPOTLIGHT

Menarini

Back to top